Viome Stock

Discovering predictive biomarkers to eradicate all diseases.

Sign up today and learn more about Viome Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Viome Stock

Viome is a team of leading entrepreneurs, scientists, and physicians. Their proven expertise is why Viome is the only private company trusted with exclusive license to technology first developed at the prestigious Los Alamos National Laboratory. Viome’s pioneering artificial learning engines are designed to not only analyze your data, but to aggregate all the biological data they receive. As the sample size grows, their machines will spot trends and influences, which will unlock scientific breakthroughs.

Funding History

July 2017$15.0M


Founder & President

Deepak Savadatti

Founder & CEO

Naveen Jain

Chief Medical Officer

Helen Messier


medium - Mar, 10 2020

Bacteria-based Diet From Viome

businessequalitymagazine - Feb, 3 2018

BEQ Presents 40 LGBTQ Leaders Under 40

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: